Pet GLP-1 Trial Updates
Where every tracked programme stands today, and what we have published. Nothing is FDA-approved for weight loss in cats or dogs. Verified 2026-08-02.
Pipeline status
| Programme | Species | Stage | Next readout |
|---|---|---|---|
| LOY-002not a GLP-1Loyal | Dogs | FDA submission underway | Company-projected launch before end of 2026estimated |
| OKV-119Okava Pharmaceuticals | Cats | Pivotal study | Summer 2027estimated |
| AKS-562cAkston Biosciences | Cats | Pilot study | H2 2026estimated |
| Slentrol (dirlotapide)not a GLP-1Pfizer Animal Health | Dogs | Discontinued | Not announced |
An estimate we derived and a date a sponsor committed to are different claims, so the confidence is printed next to every window. See the full tracker.